237 related articles for article (PubMed ID: 11139682)
1. [Cirrhosis with non alcoholic steatohepatitis: role of tamoxifen].
Dray X; Tainturier MH; De La Lande P; Marty O; Mallet L
Gastroenterol Clin Biol; 2000 Nov; 24(11):1122-3. PubMed ID: 11139682
[TBL] [Abstract][Full Text] [Related]
2. Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial.
Bruno S; Maisonneuve P; Castellana P; Rotmensz N; Rossi S; Maggioni M; Persico M; Colombo A; Monasterolo F; Casadei-Giunchi D; Desiderio F; Stroffolini T; Sacchini V; Decensi A; Veronesi U
BMJ; 2005 Apr; 330(7497):932. PubMed ID: 15746106
[TBL] [Abstract][Full Text] [Related]
3. Bezafibrate for tamoxifen-induced non-alcoholic steatohepatitis.
Saibara T; Onishi S; Ogawa Y; Yoshida S; Enzan H
Lancet; 1999 May; 353(9166):1802. PubMed ID: 10348023
[No Abstract] [Full Text] [Related]
4. Unrecognized hepatic steatosis and non-alcoholic steatohepatitis in adjuvant tamoxifen for breast cancer patients.
Murata Y; Ogawa Y; Saibara T; Nishioka A; Fujiwara Y; Fukumoto M; Inomata T; Enzan H; Onishi S; Yoshida S
Oncol Rep; 2000; 7(6):1299-304. PubMed ID: 11032933
[TBL] [Abstract][Full Text] [Related]
5. Cirrhosis with steatohepatitis after adjuvant tamoxifen.
Oien KA; Moffat D; Curry GW; Dickson J; Habeshaw T; Mills PR; MacSween RN
Lancet; 1999 Jan; 353(9146):36-7. PubMed ID: 10023952
[No Abstract] [Full Text] [Related]
6. Tamoxifen-induced submassive hepatic necrosis.
Storen EC; Hay JE; Kaur J; Zahasky K; Hartmann L
Cancer J; 2000; 6(2):58-60. PubMed ID: 11069218
[No Abstract] [Full Text] [Related]
7. Non-alcoholic steatohepatitis.
Saibara T; Onishi S; Ogawa Y; Yoshida S; Enzan H
Lancet; 1999 Oct; 354(9186):1299-300. PubMed ID: 10520659
[No Abstract] [Full Text] [Related]
8. Tamoxifen-induced non-alcoholic steatohepatitis in patients with breast cancer: determination of a suitable biopsy site for diagnosis.
Murata Y; Ogawa Y; Saibara T; Nishioka A; Takeuchi N; Kariya S; Onishi S; Yoshida S
Oncol Rep; 2003; 10(1):97-100. PubMed ID: 12469151
[TBL] [Abstract][Full Text] [Related]
9. Drug-induced steatohepatitis leading to cirrhosis: long-term toxicity of amiodarone use.
Raja K; Thung SN; Fiel MI; Chang C
Semin Liver Dis; 2009 Nov; 29(4):423-8. PubMed ID: 19826976
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen-induced transient multifocal hepatic fatty infiltration.
Cai Q; Bensen M; Greene R; Kirchner J
Am J Gastroenterol; 2000 Jan; 95(1):277-9. PubMed ID: 10638597
[TBL] [Abstract][Full Text] [Related]
11. Fatty liver and drugs.
Grieco A; Forgione A; Miele L; Vero V; Greco AV; Gasbarrini A; Gasbarrini G
Eur Rev Med Pharmacol Sci; 2005; 9(5):261-3. PubMed ID: 16237810
[TBL] [Abstract][Full Text] [Related]
12. Tamoxifen induced-non-alcoholic steatohepatitis (NASH): has the time come for the oncologist to be diabetologist.
Ahmed MH; Osman KA
Breast Cancer Res Treat; 2006 May; 97(2):223-4. PubMed ID: 16322887
[No Abstract] [Full Text] [Related]
13. Incidence and risk factors for non-alcoholic steatohepatitis in females treated with tamoxifen for breast cancer.
Akhondi-Meybodi M; Mortazavy-Zadah MR; Hashemian Z; Moaiedi M
Arab J Gastroenterol; 2011 Mar; 12(1):34-6. PubMed ID: 21429453
[TBL] [Abstract][Full Text] [Related]
14. Toremifene-induced fatty liver and NASH in breast cancer patients with breast-conservation treatment.
Hamada N; Ogawa Y; Saibara T; Murata Y; Kariya S; Nishioka A; Terashima M; Inomata T; Yoshida S
Int J Oncol; 2000 Dec; 17(6):1119-23. PubMed ID: 11078796
[TBL] [Abstract][Full Text] [Related]
15. Drugs and steatohepatitis.
Farrell GC
Semin Liver Dis; 2002; 22(2):185-94. PubMed ID: 12016549
[TBL] [Abstract][Full Text] [Related]
16. [A case of steatohepatitis associated with tamoxifen].
Kanda T; Yokosuka O; Chiba T; Kojima H; Fukai K; Imazeki F; Saisho H
Nihon Shokakibyo Gakkai Zasshi; 2002 Sep; 99(9):1119-21. PubMed ID: 12355903
[No Abstract] [Full Text] [Related]
17. Tamoxifen-induced steatohepatitis.
Pratt DS; Knox TA; Erban J
Ann Intern Med; 1995 Aug; 123(3):236. PubMed ID: 7598311
[No Abstract] [Full Text] [Related]
18. Tamoxifen-induced cirrhotic process.
Kotiloglu G; Aki ZS; Ozyilkan O; Kutlay L
Breast J; 2001; 7(6):442-3. PubMed ID: 11843860
[No Abstract] [Full Text] [Related]
19. [Chemotherapy associated hepatotoxicity in the treatment of advanced colorectal cancer (CRC)].
Tannapfel A; Reinacher-Schick A
Z Gastroenterol; 2008 May; 46(5):435-40. PubMed ID: 18461519
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen-associated steatohepatitis--report of three cases.
Pinto HC; Baptista A; Camilo ME; de Costa EB; Valente A; de Moura MC
J Hepatol; 1995 Jul; 23(1):95-7. PubMed ID: 8530816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
